Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.
2.

The effect of TNP-470 on cell proliferation and urokinase-type plasminogen activator and its inhibitor in human lung cancer cell lines.

Ishikawa H, Satoh H, Kamma H, Naito T, Ohtsuka M, Ogata T, Hasegawa S.

J Exp Ther Oncol. 1996 Nov;1(6):390-6.

PMID:
9414430
3.

AGM-1470, a potent angiogenesis inhibitor, prevents the entry of normal but not transformed endothelial cells into the G1 phase of the cell cycle.

Antoine N, Greimers R, De Roanne C, Kusaka M, Heinen E, Simar LJ, Castronovo V.

Cancer Res. 1994 Apr 15;54(8):2073-6.

4.

Cytostatic inhibition of endothelial cell growth by the angiogenesis inhibitor TNP-470 (AGM-1470).

Kusaka M, Sudo K, Matsutani E, Kozai Y, Marui S, Fujita T, Ingber D, Folkman J.

Br J Cancer. 1994 Feb;69(2):212-6.

5.
6.

Effect of 15-deoxyspergualin, a microbial angiogenesis inhibitor, on the biological activities of bovine vascular endothelial cells.

Oikawa T, Hasegawa M, Morita I, Murota S, Ashino H, Shimamura M, Kiue A, Hamanaka R, Kuwano M, Ishizuka M, et al.

Anticancer Drugs. 1992 Jun;3(3):293-9.

PMID:
1381973
7.

Characterization of TNP-470-induced modifications to cell functions in HUVEC and cancer cells.

Farinelle S, Malonne H, Chaboteaux C, Decaestecker C, Dedecker R, Gras T, Darro F, Fontaine J, Atassi G, Kiss R.

J Pharmacol Toxicol Methods. 2000 Jan-Feb;43(1):15-24.

PMID:
11091126
8.

AGM-1470 inhibits the growth of human glioblastoma cells in vitro and in vivo.

Takamiya Y, Brem H, Ojeifo J, Mineta T, Martuza RL.

Neurosurgery. 1994 May;34(5):869-75; discussion 875.

PMID:
8052385
9.

Effects of AGM-1470 and pentosan polysulphate on tumorigenicity and metastasis of FGF-transfected MCF-7 cells.

McLeskey SW, Zhang L, Trock BJ, Kharbanda S, Liu Y, Gottardis MM, Lippman ME, Kern FG.

Br J Cancer. 1996 May;73(9):1053-62.

10.

The potent angioinhibin AGM-1470 stimulates normal but not human tumoral lymphocytes.

Antoine N, Daukandt M, Locigno R, Heinen E, Simar LJ, Castronovo V.

Tumori. 1996 Jan-Feb;82(1):27-30.

PMID:
8623499
11.

The angiogenesis inhibitor AGM-1470 selectively increases E-selectin.

Budson AE, Ko L, Brasel C, Bischoff J.

Biochem Biophys Res Commun. 1996 Aug 5;225(1):141-5.

PMID:
8769107
12.

The influence of angiogenesis inhibitor AGM-1470 on immune system status and tumor growth in vitro.

Schoof DD, Obando JA, Cusack JC Jr, Goedegebuure PS, Brem H, Eberlein TJ.

Int J Cancer. 1993 Oct 21;55(4):630-5.

PMID:
7691763
13.

Potent anti-angiogenic action of AGM-1470: comparison to the fumagillin parent.

Kusaka M, Sudo K, Fujita T, Marui S, Itoh F, Ingber D, Folkman J.

Biochem Biophys Res Commun. 1991 Feb 14;174(3):1070-6.

PMID:
1705118
14.

Methionine aminopeptidase (type 2) is the common target for angiogenesis inhibitors AGM-1470 and ovalicin.

Griffith EC, Su Z, Turk BE, Chen S, Chang YH, Wu Z, Biemann K, Liu JO.

Chem Biol. 1997 Jun;4(6):461-71.

PMID:
9224570
15.

TNP-470 promotes initial vascular sprouting in xenograft tumors.

Huang J, Frischer JS, New T, Kim ES, Serur A, Lee A, Kadenhe-Chiwishe A, Pollyea DA, Yokoi A, Holash J, Yancopoulos GD, Kandel JJ, Yamashiro DJ.

Mol Cancer Ther. 2004 Mar;3(3):335-43.

16.
18.

In vitro and in vivo stimulation of the murine immune system by AGM-1470, a potent angiogenesis inhibitor.

Antoine N, Daukandt M, Heinen E, Simar LJ, Castronovo V.

Am J Pathol. 1996 Feb;148(2):393-8.

19.

Modulation of bovine microvascular endothelial cell proteolytic properties by inhibitors of angiogenesis.

Pepper MS, Vassalli JD, Wilks JW, Schweigerer L, Orci L, Montesano R.

J Cell Biochem. 1994 Aug;55(4):419-34.

PMID:
7525617
20.

TNP-470 (AGM-1470): mechanisms of action and early clinical development.

Castronovo V, Belotti D.

Eur J Cancer. 1996 Dec;32A(14):2520-7. Review. No abstract available.

PMID:
9059342

Supplemental Content

Support Center